PETNet renews Merck agreement

PETNet Solutions of Knoxville, TN, has renewed an agreement with Merck in which PETNet provides PET research isotopes to the pharmaceutical company.

As part of the deal, PETNet will continue to have an option to obtain exclusive rights for new diagnostic PET probes that Merck may develop. In addition, PETNet will synthesize PET molecular probes for Merck research and development.

Merck’s program is supported from PETNet's West Point, PA, location, according to PETNet, a subsidiary of PET developer CTI Molecular Imaging.

By staff writers
February 12, 2004

Related Reading

CTI continues growth in Q1, February 3, 2004

PETNet Solutions partners with Yerkes, January 28, 2004

PETNet signs deal with Johns Hopkins, January 27, 2004

CTI unveils Reveal Hi REZ for PET/CT, November 30, 2003

Road to RSNA, CTI Molecular Imaging, November 19, 2003

Copyright © 2004

Page 1 of 436
Next Page